Golvatinib, CAS [[928037-13-2]]

Produktübersicht

• Artikelname: Golvatinib, CAS [[928037-13-2]]
• Artikelnummer: TGM-T6517
• Hersteller Artikelnummer: T6517
• Alternativnummer: TGM-T6517-1MLX10MM(INDMSO),TGM-T6517-1MG,TGM-T6517-2MG,TGM-T6517-5MG,TGM-T6517-10MG,TGM-T6517-25MG,TGM-T6517-50MG,TGM-T6517-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: E-7050

Produktbeschreibung

Golvatinib (E-7050) is an orally bioavailable dual kinase inhibitor of c-Met (hepatocyte growth factor receptor) and VEGFR-2 (vascular endothelial growth factor receptor-2) tyrosine kinases with potential antineoplastic activity. c-Met/VEGFR kinase inhibitor E7050 binds to and inhibits the activities of both c-Met and VEGFR-2, which may inhibit tumor cell growth and survival of tumor cells that overexpress these receptor tyrosine kinases. c-Met and VEGFR-2 are upregulated in a variety of tumor cell types and play important roles in tumor cell growth, migration and angiogenesis.

Produkteigenschaften

• Molekulargewicht: 633.69
• Reinheit: 99.50%
• CAS Nummer: [928037-13-2]
• Formel: C33H37F2N7O4
• Target-Kategorie: VEGFR|||c-Met/HGFR

Bilder

T6517